Novatio Ventures Inc.

Based in Toronto, Boston and Hong Kong, we focus on the global development of innovations arising from Canada, U.S., China, South Korea, and other markets that we believe represent a significant source of opportunities for outsized value creation. We target early-stage innovation on the cusp of preclinical proof-of-concept or validation. We will provide seed funding and work actively with inventors, entrepreneurs, and institutions to devise and implement development and commercialization strategies, assemble management teams, and secure additional capital. We aim to leverage our collective experience and global industry network to achieve early exits that generate attractive, risk-mitigated financial returns.